Virtual Screening and Biological Evaluation of Potential PD-1/PD-L1 Immune Checkpoint Inhibitors as Anti-Hepatocellular Carcinoma Agents

por Kamal, Monica A., Badary, Hedy A., Omran, Dalia, Shousha, Hend I., Abdelaziz, Ashraf O., El Tayebi, Hend M., Mandour, Yasmine M.
Publicado 2023

Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians

por Youssef, Samar Samir, Elfiky, Asmaa, Nabeel, Mohamed M, Shousha, Hend Ibrahim, Elbaz, Tamer, Omran, Dalia, Marie, Mohammad Saeed, Elzahry, Mohammad A, Abul-Fotouh, Amr, Hashem, Ahmed, Guda, Mohamed F, Abdelaziz, Ashraf O
Publicado 2022

Africa Guidelines for Hepatocellular Carcinoma Buildup Process

por Abou-Alfa, Ghassan K., Afihene, Mary, Capanu, Marinela, Li, Yuelin, Chou, Joanne F., Asombang, Akwi, Alatise, Olusegun Isaac, Bounedjar, Adda, Cunha, Lina, Mekonnen, Hailemichael Desalegn, Diop, Papa Saloum, Elwakil, Reda, Ali, Mahamat Moussa, Ndlovu, Ntokozo, Ndumbalo, Jerry, Makondi, Precious Takondwa, Tzeuton, Christian, Biachi de Castria, Tiago, Agyei-Nkansah, Adwoa Afrakoma, Balogun, Fiyinfolu, Bougouma, Alain, Atipo Ibara, Blaise Irénée, Jonas, Eduard, Kimani, Stephen, Kingham, Peter, Kurrimbukus, Reshad, Hammad, Nazik, Fouad, Mona, El Baghdady, Noha, Servais Albert Fiacre, Eloumou Bagnaka, Sewram, Vikash, Spearman, C. Wendy, Yang, Ju Dong, Roberts, Lewis R., Abdelaziz, Ashraf O.
Publicado 2023